{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:49:05Z","timestamp":1791614945347,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Genome-wide association studies that scan the genome for common genetic variants associated with phenotype have greatly advanced medical knowledge. Hyperuricemia is no exception, with 28 loci identified. However, genetic control of pathways determining gout in the presence of hyperuricemia is still poorly understood. Two important pathways determining hyperuricemia have been confirmed (renal and gut excretion of uric acid with glycolysis now firmly implicated). Major urate loci are\n                    <jats:italic>SLC2A9<\/jats:italic>\n                    and\n                    <jats:italic>ABCG2.<\/jats:italic>\n                    Recent studies show that SLC2A9 is involved in renal and gut excretion of uric acid and is implicated in antioxidant defense. Although etiological variants at\n                    <jats:italic>SLC2A9<\/jats:italic>\n                    are yet to be identified, it is clear that considerable genetic complexity exists at the\n                    <jats:italic>SLC2A9<\/jats:italic>\n                    locus, with multiple statistically independent genetic variants and local epistatic interactions. The positions of implicated genetic variants within or near chromatin regions involved in transcriptional control suggest that this mechanism (rather than structural changes in SLC2A9) is important in regulating the activity of SLC2A9. ABCG2 is involved primarily in extra-renal uric acid under-excretion with the etiological variant influencing expression. At the other 26 loci, probable causal genes can be identified at three (\n                    <jats:italic>PDZK1<\/jats:italic>\n                    ,\n                    <jats:italic>SLC22A11<\/jats:italic>\n                    , and\n                    <jats:italic>INHBB<\/jats:italic>\n                    ) with strong candidates at a further 10 loci. Confirmation of the causal gene will require a combination of re-sequencing, trans-ancestral mapping, and correlation of genetic association data with expression data. As expected, the urate loci associate with gout, although inconsistent effect sizes for gout require investigation. Finally, there has been no genome-wide association study using clinically ascertained cases to investigate the causes of gout in the presence of hyperuricemia. In such a study, use of asymptomatic hyperurcemic controls would be expected to increase the ability to detect genetic associations with gout.\n                  <\/jats:p>","DOI":"10.1186\/s13075-015-0609-2","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T09:49:57Z","timestamp":1428486597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["An update on the genetic architecture of hyperuricemia and gout"],"prefix":"10.1186","volume":"17","author":[{"given":"Tony R","family":"Merriman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"key":"609_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","volume":"82","author":"EW Campion","year":"1987","unstructured":"Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987;82:421\u20136.","journal-title":"Am J Med"},{"key":"609_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2952","volume":"12","author":"N Busso","year":"2010","unstructured":"Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther. 2010;12:206.","journal-title":"Arthritis Res Ther."},{"key":"609_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.maturitas.2014.05.001","volume":"78","author":"P Robinson","year":"2014","unstructured":"Robinson P, Horsburgh S. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas. 2014;78:245\u201351.","journal-title":"Maturitas."},{"key":"609_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A K\u00f6ttgen","year":"2013","unstructured":"K\u00f6ttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45:145\u201354.","journal-title":"Nat Genet."},{"key":"609_CR5","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, K\u00f6ttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372:1953\u201361.","journal-title":"Lancet."},{"key":"609_CR6","doi-asserted-by":"publisher","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5:e1000504.","journal-title":"PLoS Genet."},{"key":"609_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","volume":"3","author":"Q Yang","year":"2010","unstructured":"Yang Q, K\u00f6ttgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet. 2010;3:523\u201330.","journal-title":"Circ Cardiovasc Genet."},{"key":"609_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.rdc.2014.01.009","volume":"40","author":"TR Merriman","year":"2014","unstructured":"Merriman TR, Choi HK, Dalbeth N. The genetic basis of gout. Rheum Dis Clin North Am. 2014;40:279\u201390.","journal-title":"Rheum Dis Clin North Am."},{"key":"609_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jbspin.2010.02.027","volume":"78","author":"TR Merriman","year":"2011","unstructured":"Merriman TR, Dalbeth N. The genetic basis of hyperuricaemia and gout. Joint Bone Spine. 2011;78:35\u201340.","journal-title":"Joint Bone Spine."},{"key":"609_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrrheum.2012.144","volume":"8","author":"AM Reginato","year":"2012","unstructured":"Reginato AM, Mount DB, Yang I, Choi HK. The genetics of hyperuricaemia and gout. Nat Rev Rheumatol. 2012;8:610\u201321.","journal-title":"Nat Rev Rheumatol."},{"key":"609_CR11","doi-asserted-by":"publisher","first-page":"R177","DOI":"10.1093\/hmg\/ddp369","volume":"18","author":"PL Riches","year":"2009","unstructured":"Riches PL, Wright AF, Ralston SH. Recent insights into the pathogenesis of hyperuricaemia and gout. Hum Mol Genet. 2009;18:R177\u201384.","journal-title":"Hum Mol Genet."},{"key":"609_CR12","doi-asserted-by":"crossref","unstructured":"Phipps-Green AJ, Merriman ME, Topless R, Altaf S, Montgomery GW, Franklin C, et al. Twenty-eight loci that influence serum urate levels: analysis of association with gout. Ann Rheum Dis. 2014;Sep 3. pii: annrheumdis-2014-205877. doi:10.1136\/annrheumdis-2014-205877. [Epub ahead of print].","DOI":"10.1136\/annrheumdis-2014-205877"},{"key":"609_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3899\/jrheum.121244","volume":"40","author":"W Urano","year":"2013","unstructured":"Urano W, Taniguchi A, Inoue E, Sekita C, Ichikawa N, Koseki Y, et al. Effect of genetic polymorphisms on development of gout. J Rheumatol. 2013;40:1374\u20138.","journal-title":"J Rheumatol."},{"key":"609_CR14","doi-asserted-by":"publisher","first-page":"e84996","DOI":"10.1371\/journal.pone.0084996","volume":"9","author":"T Kimura","year":"2014","unstructured":"Kimura T, Takahashi M, Yan K, Sakurai H. Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells. PLoS One. 2014;9:e84996.","journal-title":"PLoS One."},{"key":"609_CR15","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1371\/journal.pmed.0050197","volume":"7","author":"MJ Caulfield","year":"2008","unstructured":"Caulfield MJ, Munroe PB, O\u2019Neill D, Witkowska K, Charchar FJ, Doblado M, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med. 2008;7:e197.","journal-title":"PLoS Med."},{"key":"609_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng.107","volume":"40","author":"A Doring","year":"2008","unstructured":"Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008;40:430\u20136.","journal-title":"Nat Genet."},{"key":"609_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ng.106","volume":"40","author":"V Vitart","year":"2008","unstructured":"Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008;40:437\u201342.","journal-title":"Nat Genet."},{"key":"609_CR18","doi-asserted-by":"publisher","first-page":"15501","DOI":"10.1073\/pnas.0904411106","volume":"106","author":"F Preitner","year":"2009","unstructured":"Preitner F, Bonny O, Laverri\u00e8re A, Rotman S, Firsov D, Da Costa A, et al. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci U S A. 2009;106:15501\u20136.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"609_CR19","doi-asserted-by":"publisher","first-page":"F527","DOI":"10.1152\/ajprenal.00134.2012","volume":"15","author":"KSK Witkowska","year":"2012","unstructured":"Witkowska KSK, Yao SY, Ng AM, O\u2019Neill D, Karpinski E, Young JD, et al. Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses. Am J Physiol Renal Physiol. 2012;15:F527\u201339.","journal-title":"Am J Physiol Renal Physiol."},{"key":"609_CR20","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/ncomms5642","volume":"5","author":"B DeBosch","year":"2014","unstructured":"DeBosch B, Kluth O, Fujiwara H, Sch\u03cbrmann A, Moley KH. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter Slc2a9. Nat Commun. 2014;5:4642.","journal-title":"Nat Commun."},{"key":"609_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MNH.0b013e32832ee3de","volume":"18","author":"C Cheeseman","year":"2009","unstructured":"Cheeseman C. Solute carrier family 2, member 9 and uric acid homeostasis. Curr Op Nephrol Hypertens. 2009;18:428\u201332.","journal-title":"Curr Op Nephrol Hypertens."},{"key":"609_CR22","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78:6858\u201362.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"609_CR23","first-page":"295","volume":"121","author":"RJ Johnson","year":"2010","unstructured":"Johnson RJ, Andrews P, Benner SA, Oliver W, Theodore E. Woodward award. The evolution of obesity: insights from the mid-miocene. Trans Am Clin Climatol Assoc. 2010;121:295\u2013305.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"609_CR24","doi-asserted-by":"crossref","unstructured":"Itahana Y, Han R, Barbier S, Lei Z, Rozen S, Itahana K. The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense. Oncogene. 2014 May 26 [Epub ahead of print].","DOI":"10.1038\/onc.2014.119"},{"key":"609_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/CEJ.0b013e328313631a","volume":"18","author":"P Boffetta","year":"2009","unstructured":"Boffetta P, Nordenvall C, Nyr\u00e9n O, Ye W. A prospective study of gout and cancer. Eur J Cancer Prev. 2009;18:127\u201332.","journal-title":"Eur J Cancer Prev."},{"key":"609_CR26","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1136\/annrheumdis-2013-203600","volume":"73","author":"C Batt","year":"2014","unstructured":"Batt C, Phipps-Green A, Black MA, Cadzow M, Merriman ME, Topless R, et al. Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis. 2014;73:2101\u20136.","journal-title":"Ann Rheum Dis."},{"key":"609_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.23245","volume":"59","author":"JW Choi","year":"2008","unstructured":"Choi JW, Ford ES, Gao X, Choi HK. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2008;59:109\u201316.","journal-title":"Arthritis Rheum."},{"key":"609_CR28","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1136\/annrheumdis-2012-202732","volume":"72","author":"N Dalbeth","year":"2013","unstructured":"Dalbeth N, House ME, Gamble GD, Horne A, Pool B, Purvis L, et al. Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load. Ann Rheum Dis. 2013;72:1868\u201373.","journal-title":"Ann Rheum Dis."},{"key":"609_CR29","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1002\/art.24938","volume":"60","author":"JE Hollis-Moffatt","year":"2009","unstructured":"Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island and Caucasian case\u2013control sample sets. Arthritis Rheum. 2009;60:3485\u201392.","journal-title":"Arthritis Rheum."},{"key":"609_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng.2352","volume":"44","author":"Y Okada","year":"2012","unstructured":"Okada Y, Sim X, Go MJ, Wu JY, Gu D, Takeuchi F, et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in east asian populations. Nat Genet. 2012;44:904\u20139.","journal-title":"Nat Genet."},{"key":"609_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2156-15-81","volume":"15","author":"RB Scharpf","year":"2014","unstructured":"Scharpf RB, Mireles L, Yang Q, K\u00f6ttgen A, Ruczinski I, Susztak K, et al. Copy number polymorphisms near slc2a9 are associated with serum uric acid concentrations. BMC Genet. 2014;15:81.","journal-title":"BMC Genet."},{"key":"609_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/ard.2007.075028","volume":"67","author":"C McKinney","year":"2008","unstructured":"McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis. 2008;67:409\u201313.","journal-title":"Ann Rheum Dis."},{"key":"609_CR33","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1093\/hmg\/dds039","volume":"21","author":"C McKinney","year":"2012","unstructured":"McKinney C, Merriman TR. Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes. Hum Mol Genet. 2012;21:2370\u20136.","journal-title":"Hum Mol Genet."},{"key":"609_CR34","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1093\/hmg\/ddu227","volume":"23","author":"W-H Wei","year":"2014","unstructured":"Wei W-H, Guo Y, Kindt AS, Merriman TR, Semple CA, Wang K, et al. Abundant local interactions in the 4p16. 1 region suggest functional mechanisms underlying SLC2A9 associations with human serum uric acid. Hum Mol Genet. 2014;23:5061\u20138.","journal-title":"Hum Mol Genet"},{"key":"609_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/rheumatology\/ken460","volume":"48","author":"N Dalbeth","year":"2009","unstructured":"Dalbeth N, Merriman T. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. Rheumatol. 2009;48:222\u20136.","journal-title":"Rheumatol."},{"key":"609_CR36","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"OM Woodward","year":"2009","unstructured":"Woodward OM, K\u00f6ttgen A, Coresh J, Boerwinkle E, Guggino WB, K\u00f6ttgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A. 2009;106:10338\u201342.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"609_CR37","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1073\/pnas.1214530110","volume":"110","author":"OM Woodward","year":"2013","unstructured":"Woodward OM, Tukaye DN, Cui J, Greenwell P, Constantoulakis LM, Parker BS, et al. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules. Proc Natl Acad Sci U S A. 2013;110:5223\u20138.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"609_CR38","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756","volume":"3","author":"K Ichida","year":"2012","unstructured":"Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3:764.","journal-title":"Nat Commun."},{"key":"609_CR39","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/ar4463","volume":"16","author":"N Dalbeth","year":"2014","unstructured":"Dalbeth N, House ME, Gamble GD, Pool B, Horne A, Purvis L, et al. Influence of the ABCG2 gout risk 141\u00a0K allele on urate metabolism during a fructose challenge. Arthritis Res Ther. 2014;16:R34.","journal-title":"Arthritis Res Ther."},{"key":"609_CR40","doi-asserted-by":"publisher","first-page":"e1000534","DOI":"10.1371\/journal.pgen.1000534","volume":"5","author":"S Raychaudhuri","year":"2009","unstructured":"Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, Purcell SM, Sklar P, et al. Identifying relationships among genomic disease regions: Predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 2009;5:e1000534.","journal-title":"PLoS Genet."},{"key":"609_CR41","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1222794","volume":"337","author":"MT Maurano","year":"2012","unstructured":"Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337:1190\u20135.","journal-title":"Science"},{"key":"609_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature13138","volume":"507","author":"S Smemo","year":"2014","unstructured":"Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, G\u00f3mez-Mar\u00edn C, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507:371\u20135.","journal-title":"Nature."},{"key":"609_CR43","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00296-013-2922-x","volume":"34","author":"A Gosling","year":"2014","unstructured":"Gosling A, Matisoo-Smith E, Merriman TR. Hyperuricaemia in the Pacific: why the elevated serum urate levels? Rheumatol Int. 2014;34:743\u201357.","journal-title":"Rheumatol Int."},{"key":"609_CR44","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","volume":"51","author":"D Winnard","year":"2012","unstructured":"Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ, et al. National prevalence of gout derived from administrative data in New Zealand. Rheumatology. 2012;51:901\u20139.","journal-title":"Rheumatology"},{"key":"609_CR45","doi-asserted-by":"publisher","first-page":"R220","DOI":"10.1186\/ar4417","volume":"15","author":"T Flynn","year":"2013","unstructured":"Flynn T, Phipps-Green A, Hollis-Moffatt JE, Merriman ME, Topless R, Montgomery GW, et al. Association analysis of the SLC22A11 (OAT4) and SLC22A11 (URAT1) urate transporter locus with gout in New Zealand case\u2013control sample sets reveals multiple ancestral-specific effects. Arthritis Res Ther. 2013;15:R220.","journal-title":"Arthritis Res Ther."},{"key":"609_CR46","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.semnephrol.2011.08.005","volume":"31","author":"TR Merriman","year":"2011","unstructured":"Merriman TR. Population heterogeneity in the genetic control of serum urate. Semin Nephrol. 2011;31:420\u20135.","journal-title":"Semin Nephrol."},{"key":"609_CR47","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ki.2013.353","volume":"85","author":"K Hughes","year":"2014","unstructured":"Hughes K, Flynn T, de Zoysa J, Dalbeth N, Merriman TR. Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. Kidney Int. 2014;85:344\u201351.","journal-title":"Kidney Int."},{"key":"609_CR48","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/ije\/dyp397","volume":"39","author":"PMCH McKeigue","year":"2010","unstructured":"McKeigue PMCH, Wild S, Vitart V, Hayward C, Rudan I, Wright AF, et al. Bayesian methods for instrumental variable analysis with genetic instruments (\u2018mendelian randomization\u2019): example with urate transporter slc2a9 as an instrumental variable for effect of urate levels on metabolic syndrome. Int J Epidemiol. 2010;39:907\u201318.","journal-title":"Int J Epidemiol."},{"key":"609_CR49","doi-asserted-by":"publisher","first-page":"f4262","DOI":"10.1136\/bmj.f4262","volume":"347","author":"TM Palmer","year":"2013","unstructured":"Palmer TM, Nordestgaard BG, Benn M, Tybj\u00e6rg-Hansen A, Smith GD, Lawlor DA, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomization analysis of two large cohorts. BMJ. 2013;347:f4262.","journal-title":"BMJ."},{"key":"609_CR50","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCGENETICS.114.000556","volume":"7","author":"H Rasheed","year":"2014","unstructured":"Rasheed H, Hughes K, Flynn TJ, Merriman TR. Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels. Circ Cardiovasc Genet. 2014;7:830\u20137.","journal-title":"Circ Cardiovasc Genet."},{"key":"609_CR51","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.amjmed.2011.11.010","volume":"125","author":"E Krishnan","year":"2012","unstructured":"Krishnan E, Lessov-Schlaggar CN, Krasnow RE, Swan GE. Nature versus nurture in gout: a twin study. Am J Med. 2012;125:499\u2013504.","journal-title":"Am J Med."},{"key":"609_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747\u201353.","journal-title":"Nature"},{"key":"609_CR53","doi-asserted-by":"publisher","first-page":"R177","DOI":"10.1186\/ar4366","volume":"15","author":"H Rasheed","year":"2013","unstructured":"Rasheed H, Phipps-Green A, Topless R, Hollis-Moffatt JE, Hindmarsh JH, Franklin C, et al. Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption. Arthritis Res Ther. 2013;15:R177.","journal-title":"Arthritis Res Ther."},{"key":"609_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/annrheumdis-2011-201186","volume":"72","author":"MA McAdams-DeMarco","year":"2013","unstructured":"McAdams-DeMarco MA, Maynard JW, Baer AN, Kao LW, K\u00f6ttgen A, Coresh J. A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study. Ann Rheum Dis. 2013;72:701\u20136.","journal-title":"Ann Rheum Dis."},{"key":"609_CR55","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00439-012-1151-9","volume":"131","author":"J Wang","year":"2012","unstructured":"Wang J, Liu S, Wang B, Miao Z, Han L, Chu N, et al. Association between gout and polymorphisms in GCKR in male Han Chinese. Hum Genet. 2012;131:1261\u20135.","journal-title":"Hum Genet."},{"key":"609_CR56","doi-asserted-by":"publisher","first-page":"e64845","DOI":"10.1371\/journal.pone.0064845","volume":"8","author":"YF Qing","year":"2013","unstructured":"Qing YF, Zhou JG, Zhang QB, Wang DS, Li M, Yang QB, et al. Association of TLR4 gene rs2149356 polymorphism with primary gouty arthritis in a case\u2013control study. PLoS One. 2013;8:e64845.","journal-title":"PLoS One."},{"key":"609_CR57","volume":"73","author":"T Merriman","year":"2014","unstructured":"Merriman T, Topless R, Day R, Kannangara D, Williams K, Bradbury L, et al. Association of the toll-like receptor 4 (TLR4) gene with gout. Ann Rheum Dis. 2014;73, THU0493.","journal-title":"Ann Rheum Dis"},{"key":"609_CR58","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/ar3816","volume":"14","author":"JE Hollis-Moffatt","year":"2012","unstructured":"Hollis-Moffatt JE, Phipps-Green AJ, Chapman B, Jones GT, van Rij A, Gow PJ, et al. The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther. 2012;14:R92.","journal-title":"Arthritis Res Ther."},{"key":"609_CR59","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/ard.2008.106856","volume":"6","author":"W Urano","year":"2010","unstructured":"Urano W, Taniguchi A, Anzai N, Inoue E, Kanai Y, Yamanaka M, et al. Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis. 2010;6:1232\u20134.","journal-title":"Ann Rheum Dis."},{"key":"609_CR60","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1093\/hmg\/ddu362","volume":"23","author":"JA Bonomo","year":"2014","unstructured":"Bonomo JA, Guan M, Ng MC, Palmer ND, Hicks PJ, Keaton JM, et al. The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease. Hum Mol Genet. 2014;23:6441\u20137.","journal-title":"Hum Mol Genet."},{"key":"609_CR61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ajhg.2013.12.016","volume":"94","author":"V Tragante","year":"2014","unstructured":"Tragante V, Barnes MR, Ganesh SK, Lanktree MB, Guo W, Franceschini N, et al. Gene-centric meta-analysis in 87,736 individuals of european ancestry identifies multiple blood-pressure-related loci. Am J Hum Genet. 2014;94:349\u201360.","journal-title":"Am J Hum Genet."},{"key":"609_CR62","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/ng.2606","volume":"45","author":"SI Berndt","year":"2013","unstructured":"Berndt SI, Gustafsson S, M\u00e4gi R, Ganna A, Wheeler E, Feitosa MF, et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45:501\u201312.","journal-title":"Nat Genet."},{"key":"609_CR63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ymgme.2014.04.007","volume":"112","author":"AT Kraja","year":"2014","unstructured":"Kraja AT, Chasman DI, North KE, Reiner AP, Yanek LR, Kilpel\u00e4inen TO, et al. Pleiotropic genes for metabolic syndrome and inflammation. Mol Genet Metab. 2014;112:317\u201338.","journal-title":"Mol Genet Metab."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0609-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0609-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0609-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0609-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T12:35:25Z","timestamp":1728909325000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0609-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0609-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725440855.793528701","asserted-by":"object"}]},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]},"assertion":[{"value":"10 April 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"98"}}